Literature DB >> 22954534

Bioluminescence based in vivo screening technologies.

Madhura Kelkar1, Abhijit De.   

Abstract

Bioluminescence is the biologically active luminescence light producing event encountered in nature. In recent years several new screening methods utilizing bioluminescent cell-based biosensors have been designed demonstrating their utility towards dynamic monitoring of a variety of cellular functions. Because luciferase is unnatural to mammalian physiology, assays utilizing specific substrates to yield a luminescent signal are attractive and serve the purpose with high sensitivity and specificity. Often genetic or chemical modifications in different luciferase-substrate system in use have afforded new functionalities making these assays even more robust. Finally, in the evolving paradigm of molecular imaging, in vivo bioluminescence imaging (BLI) has evolved as a very attractive tool for interrogating human cellular biology in rodent models. In this short review we explore various bioluminescence screening strategies developed and analyze their scope in future drug screening processes.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22954534     DOI: 10.1016/j.coph.2012.07.014

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  17 in total

1.  Bioluminescence: a versatile technique for imaging cellular and molecular features.

Authors:  Miranda A Paley; Jennifer A Prescher
Journal:  Medchemcomm       Date:  2013-12-13       Impact factor: 3.597

Review 2.  Multimodality imaging of RNA interference.

Authors:  T R Nayak; L K Krasteva; W Cai
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

3.  A Novel Fluorescent and Bioluminescent Bireporter Influenza A Virus To Evaluate Viral Infections.

Authors:  Aitor Nogales; Gines Ávila-Pérez; Javier Rangel-Moreno; Kevin Chiem; Marta L DeDiego; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2019-05-01       Impact factor: 5.103

4.  Efficient ROSA26-based conditional and/or inducible transgenesis using RMCE-compatible F1 hybrid mouse embryonic stem cells.

Authors:  Lieven Haenebalcke; Steven Goossens; Michael Naessens; Natascha Kruse; Morvarid Farhang Ghahremani; Sonia Bartunkova; Katharina Haigh; Tim Pieters; Pieterjan Dierickx; Benjamin Drogat; Omar Nyabi; Dagmar Wirth; Jody J Haigh
Journal:  Stem Cell Rev Rep       Date:  2013-12       Impact factor: 5.739

Review 5.  Imaging preclinical tumour models: improving translational power.

Authors:  Marion de Jong; Jeroen Essers; Wytske M van Weerden
Journal:  Nat Rev Cancer       Date:  2014-06-19       Impact factor: 60.716

6.  A biocompatible in vivo ligation reaction and its application for noninvasive bioluminescent imaging of protease activity in living mice.

Authors:  Aurélien Godinat; Hyo Min Park; Stephen C Miller; Ke Cheng; Douglas Hanahan; Laura E Sanman; Matthew Bogyo; Allen Yu; Gennady F Nikitin; Andreas Stahl; Elena A Dubikovskaya
Journal:  ACS Chem Biol       Date:  2013-03-29       Impact factor: 5.100

7.  A dual-color far-red to near-infrared firefly luciferin analogue designed for multiparametric bioluminescence imaging.

Authors:  Amit P Jathoul; Helen Grounds; James C Anderson; Martin A Pule
Journal:  Angew Chem Int Ed Engl       Date:  2014-09-29       Impact factor: 15.336

8.  Rapid generation of endogenously driven transcriptional reporters in cells through CRISPR/Cas9.

Authors:  Alejandro Rojas-Fernandez; Lina Herhaus; Thomas Macartney; Christophe Lachaud; Ronald T Hay; Gopal P Sapkota
Journal:  Sci Rep       Date:  2015-04-29       Impact factor: 4.379

9.  Noninvasive imaging of in vivo MuRF1 expression during muscle atrophy.

Authors:  Wei Li; Mark D Claypool; Annabelle M Friera; John McLaughlin; Kristen A Baltgalvis; Ira J Smith; Taisei Kinoshita; Kathy White; Wayne Lang; Guillermo Godinez; Donald G Payan; Todd M Kinsella
Journal:  PLoS One       Date:  2014-04-07       Impact factor: 3.240

10.  Transgenic mouse model harboring the transcriptional fusion ccl20-luciferase as a novel reporter of pro-inflammatory response.

Authors:  Martina Crispo; Laurye Van Maele; Julien Tabareau; Delphine Cayet; Agustina Errea; Ana María Ferreira; Martin Rumbo; Jean Claude Sirard
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.